US Broker Ratings

Stoke Therapeutics (STOK) Investor Outlook: A Promising Biotech with 17.3% Upside Potential

Stoke Therapeutics, Inc. (STOK), a burgeoning name in the biotechnology sector, is captivating investor interest with its promising pipeline of genetic treatments and a notable potential..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Unpacking the 82% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a frontrunner in the biotechnology sector, is making waves with its ambitious aim to revolutionize treatment methodologies for diseases with unmet..

RxSight, Inc. (RXST) Investor Outlook: Exploring a 28% Potential Upside in the Medical Devices Sector

RxSight, Inc. (RXST), a promising player in the medical technology arena, presents a unique opportunity for investors seeking exposure to the healthcare sector, specifically in the..

CareDx, Inc. (CDNA) Stock Analysis: 27.52% Potential Upside in the Healthcare Diagnostics Sector

CareDx, Inc. (CDNA), a prominent player in the healthcare diagnostics and research sector, has caught the eye of investors with its robust growth prospects and a..

InnovAge Holding Corp. (INNV) Stock Analysis: Evaluating the -24.73% Potential Downside Amid Healthcare Growth

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, specializes in providing comprehensive medical and ancillary services tailored for seniors, ensuring they can..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a 21% Potential Upside in the Healthcare Sector

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a notable player in the healthcare sector, has captured investor attention with its robust pipeline of pain management medications and promising..

Talkspace, Inc. (TALK) Stock Analysis: Exploring a 35% Upside Potential and Strong Buy Ratings

For investors looking to navigate the dynamic field of healthcare technology, Talkspace, Inc. (NASDAQ: TALK) presents a compelling opportunity. Positioned within the burgeoning sector of virtual..

OrthoPediatrics Corp. (KIDS) Stock Analysis: A 34.91% Potential Upside Amid Strong Buy Ratings

OrthoPediatrics Corp. (NASDAQ: KIDS), a pioneering player in the healthcare sector focused on pediatric orthopedic solutions, stands at a pivotal juncture for investors with a potential..

Owens & Minor, Inc. (OMI) Stock Analysis: Is the 94% Potential Upside Worth the Risk?

Owens & Minor, Inc. (NYSE: OMI), a notable player in the healthcare sector specializing in medical distribution, presents a compelling narrative for investors with its standout..

uniQure N.V. (QURE) Stock Analysis: A Potential 210% Upside in the Biotechnology Sector

For investors with an eye on the biotechnology sector, uniQure N.V. (QURE) is a fascinating opportunity. Headquartered in Amsterdam, this Dutch company is a prominent player..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: A 41.98% Potential Upside Beckons Investors

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a Massachusetts-based clinical-stage pharmaceutical company, is causing a stir in the healthcare sector with its focus on cutting-edge treatments for neurodegenerative..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Assessing a Potential 14% Upside in the Biotechnology Sector

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a compelling investment opportunity in the biotechnology sector, with a potential upside of 14.37%, according to current analyst ratings...

AxoGen, Inc. (AXGN) Stock Analysis: Strong Buy Ratings Signal a 22.88% Upside Potential

AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector specializing in medical devices for peripheral nerve regeneration and repair, has been drawing significant attention..

AnaptysBio, Inc. (ANAB) Stock Analysis: A Biotech with 21% Potential Upside

AnaptysBio, Inc. (ANAB) has recently emerged as a compelling opportunity for investors in the biotech sector, particularly those with an eye for innovative developments in immunology..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring a 61.57% Potential Upside in Precision Medicine

Relay Therapeutics, Inc. (RLAY) is capturing investor attention with its position as a clinical-stage precision medicines company in the biotechnology industry. With a market capitalization of..

Simulations Plus, Inc. (SLP) Stock Analysis: A 104% Potential Upside Despite Recent Headwinds

Simulations Plus, Inc. (NASDAQ: SLP) stands at an intriguing crossroads for investors, offering a blend of advanced technological solutions in health information services with significant potential..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Exploring a 37.94% Upside Potential in Biotech

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a dynamic player in the biotechnology sector, is catching the eye of many investors due to its ambitious pursuit of innovative..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Uncertain Waters with a Potential Downside

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates an extensive network of general acute care hospitals across the United States...

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Potential Upside of 132% Amid Rising Investor Interest

Iovance Biotherapeutics, Inc. (IOVA), a key player in the biotechnology sector, has been capturing the attention of investors with its innovative approach to cancer treatment. As..

Geron Corporation (GERN) Stock Analysis: Eyeing a 106% Potential Upside in the Biotech Arena

For investors with an appetite for high-stakes opportunities in the biotechnology sector, Geron Corporation (NASDAQ: GERN) stands out as a compelling prospect. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds